Cardiometabolic risk factors are influenced by Stearoyl-CoA Desaturase (SCD) -1 gene polymorphisms and n-3 polyunsaturated fatty acid supplementation

Molecular Nutrition and Food Research

Volumn 58, Issue 5, 2014, Pages 1079-1086

  Rudkowska, Iwona ^a,b   Julien, Pierre ^b   Couture, Patrick ^a   Lemieux, Simone ^a   Tchernof, André ^a,b   Barbier, Olivier ^b   Vohl, Marie Claude ^a,b  

^a LAVAL UNIVERSITY   (Canada)

^b LAVAL UNIVERSITY   (Canada)

Author keywords

Desaturase indices; Genetic variations; Inflammation; Nutrigenetics; Plasma lipids

Indexed keywords

ACYL COENZYME A DESATURASE; C REACTIVE PROTEIN; DOCOSAHEXAENOIC ACID; FISH OIL; GLUCOSE BLOOD LEVEL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; ICOSAPENTAENOIC ACID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PHOSPHOLIPID; SCD1 PROTEIN, HUMAN; TRIACYLGLYCEROL;

ADULT; ALLELE; BLOOD; BODY MASS; BODY WEIGHT; CARDIOVASCULAR DISEASES; COHORT ANALYSIS; DIET SUPPLEMENTATION; FEMALE; GENETICS; GENOTYPE; GLUCOSE BLOOD LEVEL; HUMAN; MALE; METABOLISM; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; YOUNG ADULT;

ADULT; ALLELES; BLOOD GLUCOSE; BODY MASS INDEX; BODY WEIGHT; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CHOLESTEROL, HDL; CHOLESTEROL, LDL; COHORT STUDIES; DIETARY SUPPLEMENTS; DOCOSAHEXAENOIC ACIDS; EICOSAPENTAENOIC ACID; FEMALE; FISH OILS; GENOTYPE; HUMANS; MALE; PHOSPHOLIPIDS; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; STEAROYL-COA DESATURASE; TRIGLYCERIDES; YOUNG ADULT;

EID: 84898931148     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201300426     Document Type: Article

References (39)

1. Flowers, M. T., Ntambi, J. M., Role of stearoyl-coenzyme A desaturase in regulating lipid metabolism. Curr. Opin. Lipidol. 2008, 19, 248-56.
2. Merino, D. M., Ma, D. W., Mutch, D. M., Genetic variation in lipid desaturases and its impact on the development of human disease. Lipids Health Dis. 2010, 9, 63.
3. Ntambi, J. M., Miyazaki, M., Recent insights into stearoyl-CoA desaturase-1. Curr. Opin. Lipidol. 2003, 14, 255-261.
4. Poudyal, H., Brown, L., Stearoyl-CoA desaturase: a vital checkpoint in the development and progression of obesity. Endocr. Metab. Immune Disord. Drug Targets. 2011, 11, 217-231.
5. Decsi, T., Csabi, G., Torok, K., Erhardt, E. et al., Polyunsaturated fatty acids in plasma lipids of obese children with and without metabolic cardiovascular syndrome. Lipids 2000, 35, 1179-1184.
6. Maruyama, C., Yoneyama, M., Suyama, N., Yoshihi, V. et al., Differences in serum phospholipid fatty acid compositions and estimated desaturase activities between Japanese men with and without metabolic syndrome. J. Atheroscler. Thromb. 2008, 15, 306-313.
7. Warensjo, E., Riserus, U., Gustafsson, I. B., Mohsen, R., Cederholm, T., Vessby, B., Effects of saturated and unsaturated fatty acids on estimated desaturase activities during a controlled dietary intervention. Nutr. Metab. Cardiovasc. Dis. 2008, 18, 683-690.
8. Caron-Jobin, M., Mauvoisin, D., Michaud, A., Veilleux, A. et al., Stearic acid content of abdominal adipose tissues in obese women. Nutr. Diabetes 2012, 2, e23.
9. Cohen, P., Miyazaki, M., Socci, N. D., Hagge-Greenberg, A. et al., Role for stearoyl-CoA desaturase-1 in leptin-mediated weight loss. Science 2002, 297, 240-243.
10. Saito, E., Okada, T., Abe, Y., Kuromori, Y. et al., Docosahexaenoic acid content in plasma phospholipids and desaturase indices in obese children. J. Atheroscler. Thromb. 2011, 18, 345-350.
11. Vessby, B., Gustafsson, I. B., Tengblad, S., Berglund, L., Indices of fatty acid desaturase activity in healthy human subjects: effects of different types of dietary fat. Br. J. Nutr. 2013, 1-9.
12. Landschulz, K. T., Jump, D. B., MacDougald, O. A., Lane, M. D., Transcriptional control of the stearoyl-CoA desaturase-1 gene by polyunsaturated fatty acids. Biochem. Biophys. Res. Commun 1994, 200, 763-768.
13. Hofacer, R., Jack, M. I., Jandacek, R., Rider, T. et al., Omega-3 fatty acid deficiency increases stearoyl-CoA desaturase expression and activity indices in rat liver: Positive association with non-fasting plasma triglyceride levels. Prostaglandins Leukot. Essent. Fatty Acids 2012, 86, 71-77.
14. Gillies, P. J., Bhatia, S. K., Belcher, L. A., Hannon, D. B. et al., Regulation of inflammatory and lipid metabolism genes by eicosapentaenoic acid-rich oil. J. Lipid Res. 2012, 53, 1679-1689.
15. Warensjo, E., Ingelsson, E., Lundmark, P., Lannfelt, L. et al., Polymorphisms in the SCD1 gene: associations with body fat distribution and insulin sensitivity. Obesity (Silver Spring) 2007, 15, 1732-1740.
16. Gong, J., Campos, H., McGarvey, S., Wu, Z., Goldberg, R., Baylin, A., Genetic variation in stearoyl-CoA desaturase 1 is associated with metabolic syndrome prevalence in Costa Rican adults. J. Nutr. 2011, 141, 2211-2218.
17. McNamara, J. R., Schaefer, E. J., Automated enzymatic standardized lipid analyses for plasma and lipoprotein fractions. Clin. Chim. Acta 1987, 166, 1-8.
18. Burstein, M., Samaille, J., On a rapid determination of the cholesterol bound to the serum alpha- and beta-lipoproteins. Clin. Chim. Acta 1960, 5, 609.
19. Albers, J. J., Warnick, G. R., Wiebe, D., King, P. et al., Multi-laboratory comparison of three heparin-Mn2+ precipitation procedures for estimating cholesterol in high-density lipoprotein. Clin. Chem. 1978, 24, 853-856.
20. Friedewald, W. T., Levy, R. I., Fredrickson, D. S., Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 1972, 18, 499-502.
21. Desbuquois, B., Aurbach, G. D., Use of polyethylene glycol to separate free and antibody-bound peptide hormones in radioimmunoassays. J. Clin. Endocrinol. Metab. 1971, 33, 732-738.
22. Richterich, R., Dauwalder, H., Determination of plasma glucose by hexokinase-glucose-6-phosphate dehydrogenase method. Schweiz. Med. Wochenschr. 1971, 101, 615-618.
23. Pirro, M., Bergeron, J., Dagenais, G. R., Bernard, P. M. et al., Age and duration of follow-up as modulators of the risk for ischemic heart disease associated with high plasma C-reactive protein levels in men. Arch. Intern. Med. 2001, 161, 2474-2480.
24. Shaikh, N. A., Downar, E., Time course of changes in porcine myocardial phospholipid levels during ischemia. A reassessment of the lysolipid hypothesis. Circ. Res. 1981, 49, 316-325.
25. Kroger, E., Verreault, R., Carmichael, P. H., Lindsay, J. et al., Omega-3 fatty acids and risk of dementia: the Canadian Study of Health and Aging. Am. J. Clin. Nutr. 2009, 90, 184-192.
26. Hulley, S. B., Cummings, S. R., Browner, W. S., Grady, D. et al., Designing Clinical Research- An Epidemiologic Approach. Second Edition, Chapter 6, pp. 65-91, 2001.
27. Saito, E., Okada, T., Abe, Y., Kuromori, Y. et al., Docosahexaenoic acid content in plasma phospholipids and desaturase indices in obese children. J. Atheroscler. Thromb. 2011, 18, 345-350.
28. Telle-Hansen, V. H., Larsen, L. N., Hostmark, A. T., Molin, M. et al., Daily intake of cod or salmon for 2 weeks decreases the 18:1n-9/18:0 ratio and serum triacylglycerols in healthy subjects. Lipids 2012, 47, 151-160.
29. Rudkowska, I., Paradis, A. M., Thifault, E., Julien, P. et al., Transcriptomic and metabolomic signatures of an n-3 polyunsaturated fatty acids supplementation in a normolipidemic/normocholesterolemic Caucasian population. J. Nutr. Biochem. 2013, 24, 54-61.
30. Ntambi, J. M., Regulation of stearoyl-CoA desaturase by polyunsaturated fatty acids and cholesterol. J. Lipid Res. 1999, 40, 1549-1558.
31. Gutierrez-Juarez, R., Pocai, A., Mulas, C., Ono, H. et al., Critical role of stearoyl-CoA desaturase-1 (SCD1) in the onset of diet-induced hepatic insulin resistance. J. Clin. Invest. 2006, 116, 1686-1695.
32. Rudkowska, I., Paradis, A. M., Thifault, E., Julien, P. et al., Differences in metabolomic and transcriptomic profiles between responders and non-responders to an n-3 polyunsaturated fatty acids (PUFAs) supplementation. Genes Nutr. 2012.
33. Balk, E. M., Lichtenstein, A. H., Chung, M., Kupelnick, B., Chew, P., Lau, J., Effects of omega-3 fatty acids on serum markers of cardiovascular disease risk: a systematic review. Atherosclerosis 2006, 189, 19-30.
34. Peter, A., Weigert, C., Staiger, H., Machicao, F. et al., Individual stearoyl-coa desaturase 1 expression modulates endoplasmic reticulum stress and inflammation in human myotubes and is associated with skeletal muscle lipid storage and insulin sensitivity in vivo. Diabetes 2009, 58, 1757-1765.
35. Stryjecki, C., Roke, K., Clarke, S., Nielsen, D. et al., Enzymatic activity and genetic variation in SCD1 modulate the relationship between fatty acids and inflammation. Mol. Genet. Metab. 2012, 105, 421-427.
36. Brown, J. M., Chung, S., Sawyer, J. K., Degirolamo, C. et al., Inhibition of stearoyl-coenzyme A desaturase 1 dissociates insulin resistance and obesity from atherosclerosis. Circulation 2008, 118, 1467-1475.
37. Corrocher, R., Pagnan, A., Ambrosio, G. B., Ferrari, S. et al., Effects induced by olive oil-rich diet on erythrocytes membrane lipids and sodium-potassium transports in postmenopausal hypertensive women. J. Endocrinol. Invest. 1992, 15, 369-376.
38. Hodson, L., Skeaff, C. M., Fielding, B. A., Fatty acid composition of adipose tissue and blood in humans and its use as a biomarker of dietary intake. Prog. Lipid Res. 2008, 47, 348-380.
39. Roberts, R., Hodson, L., Dennis, A. L., Neville, M. J. et al., Markers of de novo lipogenesis in adipose tissue: associations with small adipocytes and insulin sensitivity in humans. Diabetologia 2009, 52, 882-890.